BANDINI, CECILIA
 Distribuzione geografica
Continente #
EU - Europa 298
NA - Nord America 280
AS - Asia 110
OC - Oceania 1
SA - Sud America 1
Totale 690
Nazione #
US - Stati Uniti d'America 277
IT - Italia 215
CN - Cina 48
SG - Singapore 39
IE - Irlanda 14
SE - Svezia 14
FR - Francia 10
DE - Germania 8
ID - Indonesia 7
UA - Ucraina 7
AT - Austria 6
IN - India 4
JP - Giappone 4
PL - Polonia 4
RO - Romania 4
CA - Canada 3
GB - Regno Unito 3
NL - Olanda 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
FI - Finlandia 2
TR - Turchia 2
VN - Vietnam 2
BE - Belgio 1
BY - Bielorussia 1
CO - Colombia 1
ES - Italia 1
HK - Hong Kong 1
HR - Croazia 1
IR - Iran 1
KR - Corea 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
Totale 690
Città #
Torino 69
Turin 51
Singapore 34
Fairfield 33
Santa Clara 31
Chandler 29
Novara 25
Ashburn 16
Cambridge 14
Dublin 14
Woodbridge 13
Beijing 12
Houston 10
Nyköping 8
Pisa 8
Seattle 8
Wilmington 8
Jakarta 7
Columbus 6
Jinan 5
Vienna 5
Ann Arbor 4
Boston 4
Guangzhou 4
Jacksonville 4
Latina 4
Nanjing 4
Paris 4
Redwood City 4
Suzhou 4
Warsaw 4
Durham 3
Fremont 3
Heidelberg 3
Medford 3
Mumbai 3
New York 3
Ottawa 3
San Diego 3
Villeurbanne 3
Xian 3
Amsterdam 2
Cadoneghe 2
Dearborn 2
Flushing 2
Galati 2
Geneve 2
Lecce 2
Milan 2
Phoenix 2
Princeton 2
Rochester 2
Rome 2
San Mateo 2
Shanghai 2
West Jordan 2
Yuba City 2
Zhengzhou 2
Ankara 1
Ascoli Piceno 1
Auckland 1
Berlin 1
Bolgare 1
Brussels 1
Caselle Torinese 1
Central District 1
Centrale 1
Centreville 1
Chongqing 1
Clarks Summit 1
Guiyang 1
Hefei 1
Helsinki 1
Istanbul 1
Kansas City 1
Lappeenranta 1
Las Vegas 1
Medellín 1
Moncalieri 1
Mountain View 1
Naples 1
Ostrava 1
Palermo 1
Philadelphia 1
Piemonte 1
Pozzuoli 1
Richmond 1
Slough 1
Tokyo 1
Trieste 1
Upper Marlboro 1
Verona 1
Wigan 1
Wuhan 1
Totale 546
Nome #
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 405
IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas 164
The landscape of signaling pathways and proteasome inhibitors combinations in multiple myeloma 34
Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines 27
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins 27
Genomic instability in multiple myeloma: A “non‐coding rna” perspective 23
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma 19
Totale 699
Categoria #
all - tutte 2.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.209


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202097 0 0 0 0 9 13 24 11 15 9 8 8
2020/2021141 13 18 9 7 10 14 10 7 13 19 10 11
2021/202284 8 9 8 6 1 3 6 2 14 10 10 7
2022/2023109 5 18 2 12 9 26 5 3 11 5 10 3
2023/202472 7 11 7 2 2 9 3 4 2 9 8 8
2024/2025113 4 20 12 22 55 0 0 0 0 0 0 0
Totale 699